Cargando…

Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors

BACKGROUND: We have previously found regional differences in the prevalence of known type 2 diabetes between northeastern and southern Germany. We aim to also provide prevalence estimates for prediabetes (isolated impaired fasting glucose (i-IFG), isolated glucose intolerance (i-IGT), combined IFG a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamayo, Teresa, Schipf, Sabine, Meisinger, Christine, Schunk, Michaela, Maier, Werner, Herder, Christian, Roden, Michael, Nauck, Matthias, Peters, Annette, Völzke, Henry, Rathmann, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234669/
https://www.ncbi.nlm.nih.gov/pubmed/25402347
http://dx.doi.org/10.1371/journal.pone.0113154
_version_ 1782344892133933056
author Tamayo, Teresa
Schipf, Sabine
Meisinger, Christine
Schunk, Michaela
Maier, Werner
Herder, Christian
Roden, Michael
Nauck, Matthias
Peters, Annette
Völzke, Henry
Rathmann, Wolfgang
author_facet Tamayo, Teresa
Schipf, Sabine
Meisinger, Christine
Schunk, Michaela
Maier, Werner
Herder, Christian
Roden, Michael
Nauck, Matthias
Peters, Annette
Völzke, Henry
Rathmann, Wolfgang
author_sort Tamayo, Teresa
collection PubMed
description BACKGROUND: We have previously found regional differences in the prevalence of known type 2 diabetes between northeastern and southern Germany. We aim to also provide prevalence estimates for prediabetes (isolated impaired fasting glucose (i-IFG), isolated glucose intolerance (i-IGT), combined IFG and IGT) and unknown type 2 diabetes for both regions. METHODS: Prevalence (95%CI) of prediabetes (i-IFG: fasting glucose 5.6–6.9 mmol/l; i-IGT: 2 h postchallenge gluose 7.8–11.0 mmol/l, oral glucose tolerance test (OGTT), ≥8 h overnight fasting) and unknown diabetes were analyzed in two regional population-based surveys (age group 35–79 years): SHIP-TREND (Study of Health in Pomerania (northeast), 2008–2012) and KORA F4 (Cooperative Health Research in the region of Augsburg (south), 2006–2008). Both studies used similar methods, questionnaires, and identical protocols for OGTT. Overall, 1,980 participants from SHIP-TREND and 2,617 participants from KORA F4 were included. RESULTS: Age-sex-standardized prevalence estimates (95%CI) of prediabetes and unknown diabetes were considerably higher in the northeast (SHIP-TREND: 43.1%; 40.9–45.3% and 7.1%; 5.9–8.2%) than in the south of Germany (KORA F4: 30.1%; 28.4–31.7% and 3.9%; 3.2–4.6%), respectively. In particular, i-IFG (26.4%; 24.5–28.3% vs. 17.2%; 15.7–18.6%) and IFG+IGT (11.2%; 9.8–12.6% vs. 6.6%; 5.7–7.5%) were more frequent in SHIP-TREND than in KORA. In comparison to normal glucose tolerance, the odds of having unknown diabetes (OR, 95%CI: 2.59; 1.84–3.65) or prediabetes (1.98; 1.70–2.31) was higher in the northeast than in the south after adjustment for known risk factors (obesity, lifestyle). CONCLUSIONS: The regional differences of prediabetes and unknown diabetes are in line with the geographical pattern of known diabetes in Germany. The higher prevalences in the northeast were not explained by traditional risk factors.
format Online
Article
Text
id pubmed-4234669
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42346692014-11-21 Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors Tamayo, Teresa Schipf, Sabine Meisinger, Christine Schunk, Michaela Maier, Werner Herder, Christian Roden, Michael Nauck, Matthias Peters, Annette Völzke, Henry Rathmann, Wolfgang PLoS One Research Article BACKGROUND: We have previously found regional differences in the prevalence of known type 2 diabetes between northeastern and southern Germany. We aim to also provide prevalence estimates for prediabetes (isolated impaired fasting glucose (i-IFG), isolated glucose intolerance (i-IGT), combined IFG and IGT) and unknown type 2 diabetes for both regions. METHODS: Prevalence (95%CI) of prediabetes (i-IFG: fasting glucose 5.6–6.9 mmol/l; i-IGT: 2 h postchallenge gluose 7.8–11.0 mmol/l, oral glucose tolerance test (OGTT), ≥8 h overnight fasting) and unknown diabetes were analyzed in two regional population-based surveys (age group 35–79 years): SHIP-TREND (Study of Health in Pomerania (northeast), 2008–2012) and KORA F4 (Cooperative Health Research in the region of Augsburg (south), 2006–2008). Both studies used similar methods, questionnaires, and identical protocols for OGTT. Overall, 1,980 participants from SHIP-TREND and 2,617 participants from KORA F4 were included. RESULTS: Age-sex-standardized prevalence estimates (95%CI) of prediabetes and unknown diabetes were considerably higher in the northeast (SHIP-TREND: 43.1%; 40.9–45.3% and 7.1%; 5.9–8.2%) than in the south of Germany (KORA F4: 30.1%; 28.4–31.7% and 3.9%; 3.2–4.6%), respectively. In particular, i-IFG (26.4%; 24.5–28.3% vs. 17.2%; 15.7–18.6%) and IFG+IGT (11.2%; 9.8–12.6% vs. 6.6%; 5.7–7.5%) were more frequent in SHIP-TREND than in KORA. In comparison to normal glucose tolerance, the odds of having unknown diabetes (OR, 95%CI: 2.59; 1.84–3.65) or prediabetes (1.98; 1.70–2.31) was higher in the northeast than in the south after adjustment for known risk factors (obesity, lifestyle). CONCLUSIONS: The regional differences of prediabetes and unknown diabetes are in line with the geographical pattern of known diabetes in Germany. The higher prevalences in the northeast were not explained by traditional risk factors. Public Library of Science 2014-11-17 /pmc/articles/PMC4234669/ /pubmed/25402347 http://dx.doi.org/10.1371/journal.pone.0113154 Text en © 2014 Tamayo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tamayo, Teresa
Schipf, Sabine
Meisinger, Christine
Schunk, Michaela
Maier, Werner
Herder, Christian
Roden, Michael
Nauck, Matthias
Peters, Annette
Völzke, Henry
Rathmann, Wolfgang
Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors
title Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors
title_full Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors
title_fullStr Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors
title_full_unstemmed Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors
title_short Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors
title_sort regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234669/
https://www.ncbi.nlm.nih.gov/pubmed/25402347
http://dx.doi.org/10.1371/journal.pone.0113154
work_keys_str_mv AT tamayoteresa regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT schipfsabine regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT meisingerchristine regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT schunkmichaela regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT maierwerner regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT herderchristian regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT rodenmichael regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT nauckmatthias regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT petersannette regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT volzkehenry regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors
AT rathmannwolfgang regionaldifferencesofundiagnosedtype2diabetesandprediabetesprevalencearenotexplainedbyknownriskfactors